Прогноз гепатоцеллюлярного рака: оценка 11 систем стадирования
Po-Hong Liu1,3, Chia-Yang Hsu3,6, Cheng-Yuan Hsia2,3, Yun-Hsuan Lee1,3, Chien-Wei Su1,3, Yi-Hsiang Huang1,4, Fa-Yauh Lee1,3, Han-Chieh Lin1,3, Teh-Ia Huo1,3,5,*
1 Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 2 Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; 3 Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; 4 Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; 5 Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan; 6 Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA
*Автор, ответственный за переписку.